Roxana Maria Amarandi (Roxana-Maria Amarandi, Roxana-Maria Amărandi)

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 8

Top Venues

Pharmaceuticals (Basel, Switzerland)

Journal of enzyme inhibition and medicinal chemistry

ACS omega

Molecules (Basel, Switzerland)

Institutul Regional de Oncologie

Universitatea Alexandru Ioan Cuza Facultatea de Chimie (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Institutul Regional de Oncologie Apr 01 2020

Romania

CS III :: TRANSCEND Research Center

Universitatea Alexandru Ioan Cuza Apr 01 2019

Romania

Postdoctoral Researcher :: Chimie

Spitalul Clinic Colentina Jan 15 2018 - May 01 2018

Romania

Researcher

Universitatea Politehnica din Bucuresti Facultatea de Inginerie Medicala Aug 21 2017 - Jan 03 2018

Romania

Researcher

University of Copenhagen Mar 01 2016 - May 01 2016

Denmark

Visiting PhD Student :: Department of Neuroscience and Pharmacology, Laboratory for Molecular Pharmacology

Education History

Universitatea Alexandru Ioan Cuza Facultatea de Chimie Oct 01 2013 - Jul 21 2017

Romania

PHD

Universitatea Alexandru Ioan Cuza Facultatea de Biologie Oct 03 2011 - Jul 08 2013

Romania

MSC

Universitatea Alexandru Ioan Cuza Facultatea de Chimie Oct 01 2008 - Jul 03 2011

Romania

BSC

Publications

Roxana Maria Amarandi, Andrei Neamṭu, Rareș Ionuț Știufiuc, Luminita Marin, Brindusa Dragoi
Impact of Lipid Composition on Vesicle Protein Adsorption: A BSA Case Study. ACS omega 9 (16) (2024)
Roxana Maria Amarandi, Andrei Neamṭu, Rareș Ionuț Știufiuc, Luminita Marin, Brindusa Dragoi
Impact of Lipid Composition on Vesicle Protein Adsorption: A BSA Case Study. ACS omega 9 (16) (2024)
Roxana Maria Amarandi, Cristina-Maria Al Matarneh, Lăcrămioara Popovici, Catalina Ionica Ciobanu, Andrei Neamțu, Ionel I Mangalagiu, Ramona Danac
Exploring Pyrrolo-Fused Heterocycles as Promising Anticancer Agents: An Integrated Synthetic, Biological, and Computational Approach. Pharmaceuticals (Basel, Switzerland) 16 (6) (2023)
Roxana Maria Amarandi, Cristina-Maria Al Matarneh, Lăcrămioara Popovici, Catalina Ionica Ciobanu, Andrei Neamțu, Ionel I Mangalagiu, Ramona Danac
Exploring Pyrrolo-Fused Heterocycles as Promising Anticancer Agents: An Integrated Synthetic, Biological, and Computational Approach. Pharmaceuticals (Basel, Switzerland) 16 (6) (2023)
Roxana Maria Amarandi, Alina Ibanescu, Eugen Carasevici, Luminita Marin, Brindusa Dragoi
Liposomal-Based Formulations: A Path from Basic Research to Temozolomide Delivery Inside Glioblastoma Tissue. Pharmaceutics 14 (2) (2022)
Maria Cristina Al-Matarneh, Roxana Maria Amarandi, Ionel I Mangalagiu, Ramona Danac
Synthesis and Biological Screening of New Cyano-Substituted Pyrrole Fused (Iso)Quinoline Derivatives. Molecules (Basel, Switzerland) 26 (7) (2021)
Monica-Cornelia Sardaru, Anda Mihaela Craciun, Cristina-Maria Al Matarneh, Isabela Andreea Sandu, Roxana Maria Amarandi, Lacramioara Popovici, Catalina Ionica Ciobanu, Dragos Peptanariu, Mariana Pinteala, Ionel I Mangalagiu, Ramona Danac
Cytotoxic substituted indolizines as new colchicine site tubulin polymerisation inhibitors. Journal of enzyme inhibition and medicinal chemistry 35 (1) (2021)
Lacramioara Popovici, Roxana Maria Amarandi, Ionel I Mangalagiu, Violeta Mangalagiu, Ramona Danac
Synthesis, molecular modelling and anticancer evaluation of new pyrrolo[1,2-b]pyridazine and pyrrolo[2,1-a]phthalazine derivatives. Journal of enzyme inhibition and medicinal chemistry 34 (1) (2019)

Roxana Maria Amarandi.css-eqlu8i{font-size:small;padding-left:4px;} (Roxana-Maria Amarandi, Roxana-Maria Amărandi)

Publication Activity (10 Years)

Top Topics

Top Venues

Roxana Maria Amarandi (Roxana-Maria Amarandi, Roxana-Maria Amărandi)